Home

Clinical Treatment Trials

The research studies listed below are currently recruiting volunteers to participate.

For each study there is a brief description and contact information.


Depression in Pediatric and Adolescents

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 7-17 years of age for a double-blind, clinical trial using Vilazodone for the treatment of pediatric and adolescent major depressive disorder. After completion of the 8-week study, subjects are eligible for a 6-month open-label trial of Vilazodone.

For more information about this trial, please contact:

Dr. Salma Malik
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org

Back to Top


Esketamine Study for Treatment-Resistant Depressive Disorder

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-64 years of age for a clinical research study for patients with depression who have not responded to prior treatment with an antidepressant.

For more information about this trial, please contact:

Dr. Andrew Winokur
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org

Back to Top


Sertraline Pediatric Registry (SPRITES)

This non-interventional study will examine the risks and benefits of up to 3 years of treatment with sertraline on cognition, emotional and physical development, and pubertal maturation in children ages 6 to 14 years. Recruitment Needs: Patients ages 6-14 diagnosed with an anxiety or depressive disorder that are starting sertraline or starting therapy but not taking sertraline, with an IOL psychiatrist or psychologist. This study will not alter treatment regimen.

For more information about this trial, please contact:

Dr. Salma Malik
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org

Back to Top


The research studies on clinicaltrials.gov are currently recruiting volunteers to participate.

Become an integral part of our research and quality practices by volunteering to participate in one of our many innovative clinical trials. Your contribution will aid in developing the safest and most effective treatments and medical practices possible. We couldn’t do it without your help.

clinicaltrials.gov